| P50 | author | Erik De Clercq | Q13578863 |
| P2093 | author name string | K Andries | |
| | R Pauwels | |
| | Z Debyser | |
| P2860 | cites work | Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives | Q28323202 |
| | Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor | Q28323582 |
| | An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk] [1,4]benzodiazepin-2 (1H)-one and -thione derivatives | Q28323682 |
| | A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site | Q28323713 |
| | Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptase | Q28323740 |
| | Genome organization and transactivation of the human immunodeficiency virus type 2. | Q34048704 |
| | Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. | Q34382153 |
| | New acquisitions in the development of anti-HIV agents | Q38368612 |
| | Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative | Q41757646 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 47-53 | |
| P577 | publication date | 1992-01-01 | |
| P1433 | published in | Journal of Enzyme Inhibition and Medicinal Chemistry | Q15708877 |
| P1476 | title | Specific HIV-1 reverse transcriptase inhibitors | |
| P478 | volume | 6 | |